* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Diamond Biotechnology Co's PEG Ratio or its related term are showing as below:
ROCO:6815'
s PEG Ratio Range Over the Past 10 Years
Min: 38.69 Med: 42.64 Max: 49.11
Current: 43.78
During the past 7 years, Diamond Biotechnology Co's highest PEG Ratio was 49.11. The lowest was 38.69. And the median was 42.64.
ROCO:6815's PEG Ratio is ranked worse than 96.77% of 248
companies
in the Medical Devices & Instruments industry
Industry Median: 1.98
vs ROCO:6815: 43.78
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Diamond Biotechnology Co PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Diamond Biotechnology Co's PEG Ratio
For the Medical Devices subindustry, Diamond Biotechnology Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diamond Biotechnology Co's PEG Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Diamond Biotechnology Co's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Diamond Biotechnology Co's PEG Ratio falls into.
Diamond Biotechnology Co PEG Ratio Calculation
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio.
The ratio we use is the 5-Year EBITDA growth rate.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Diamond Biotechnology Co (ROCO:6815) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Diamond Biotechnology Co PEG Ratio Related Terms
Thank you for viewing the detailed overview of Diamond Biotechnology Co's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Diamond Biotechnology Co (ROCO:6815) Business Description
Diamond Biotechnology Co Ltd is engaged in the research and development of medical equipment, and medical consumables. It also manufactures and sells medical beauty-level skincare products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ROCO:6815 has been successfully added to your 